Frontotemporal Dementia
115
23
36
53
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Published Results
13 trials with published results (11%)
Research Maturity
53 completed trials (46% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
3.5%
4 terminated out of 115 trials
93.0%
+6.4% vs benchmark
5%
6 trials in Phase 3/4
25%
13 of 53 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 53 completed trials
Clinical Trials (115)
Non-invasive Neurostimulation as a Tool for Diagnostics and Management for Neurodegenerative Diseases
A Phase 3 Study to Evaluate Efficacy and Safety of AL001 in Frontotemporal Dementia (INFRONT-3)
Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Open-label Extension (OLE) Study of WVE-004 in Patients With C9orf72-associated Amyotrophic Lateral Sclerosis (ALS) and/or Frontotemporal Dementia (FTD)
Safety and Therapeutic Potential of the FDA-approved Drug Metformin for C9orf72 ALS/FTD
Using the EHR to Advance Genomic Medicine Across a Diverse Health System
A Study to Evaluate the Safety and Effect of AVB-101, a Gene Therapy Product, in Subjects With a Genetic Sub-type of Frontotemporal Dementia (FTD-GRN)
Sociodemographic Factors and Criminal Behaviour Preceding Neurodegenerative Disease - Retrospective Register Study
Nabilone for Agitation in Frontotemporal Dementia
Phase 1/2 Clinical Trial of LY3884963 in Patients With Frontotemporal Dementia With Progranulin Mutations (FTD-GRN)
MSC-Exosome Therapy for Frontotemporal Dementia
Neurologic Stem Cell Treatment Study
Imaging of Brain Amyloid Plaques in the Aging Population
Neurofilament Surveillance Project (NSP)
Phenotype, Genotype and Biomarkers 2
Phenotype, Genotype & Biomarkers in ALS and Related Disorders
TRIAL READY (Clinical Trial Readiness)
Quantitative Evaluation of Apathy Close to Real Life Situation by Means of a Multimodal Sensor System Integrated.
A Study of Caregiver Connections Via Technology in Dementia
GENetic Fronto Temporal Dementia Initiative in Lille